Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Oehrle, Bettina ^a   Burgstaller, Gerald ^a   Irmler, Martin ^b   Dehmel, Stefan ^a   Grün, Jessica ^a   Hwang, Tiffany ^a   Krauss Etschmann, Susanne ^a   Beckers, Johannes ^b,c   Meiners, Silke ^a   Eickelberg, Oliver ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SIGNAL PEPTIDE; TRANSCRIPTOME;

ANIMAL; CELL LINE; CELL MOTION; CLUSTER ANALYSIS; DNA MICROARRAY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELL LINE; CELL MOVEMENT; CLUSTER ANALYSIS; FIBROBLASTS; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTOME;

EID: 84938935469     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12673     Document Type: Article

References (60)

1. Lauffenburger, D. A. & Horwitz, A. F. Cell migration: a physically integrated molecular process. Cell 84, 359-369 (1996).
2. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat Rev Cancer 6, 392-401 (2006).
3. Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337 (2004).
4. Friedl, P., Zanker, K. S. & Brocker, E. B. Cell migration strategies in 3-D extracellular matrix: differences in morphology, cell matrix interactions, and integrin function. Microsc Res Tech 43, 369-378 (1998).
5. Schmidt, S. & Friedl, P. Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res 339, 83-92 (2010).
6. Klingberg, F., Hinz, B. & White, E. S. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol 229, 298-309 (2013).
7. Hardie, W. D., Glasser, S. W. & Hagood, J. S. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175, 3-16 (2009).
8. Cool, C. D. et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 174, 654-658 (2006).
9. Nasreen, N. et al. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 297, L115-124 (2009).
10. Zolak, J. S. et al. Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury. Am J Pathol 182, 1239-1247 (2013).
11. Laurent, G. J., McAnulty, R. J., Hill, M. & Chambers, R. Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis. Proc Am Thorac Soc 5, 311-315 (2008).
12. Willis, B. C. & Borok, Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293, L525-534 (2007).
13. Coker, R. K. & Laurent, G. J. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11, 1218-1221 (1998).
14. Li, Y. et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 208, 1459-1471 (2011).
15. Dienus, K., Bayat, A., Gilmore, B. F. & Seifert, O. Increased expression of fibroblast activation protein-Alpha in keloid fibroblasts: implications for development of a novel treatment option. Arch Dermatol Res 302, 725-731 (2010).
16. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
17. Otranto, M. et al. The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr 6, 203-219 (2012).
18. Gaggioli, C. et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9, 1392-1400 (2007).
19. Burgstaller, G., Oehrle, B., Koch, I., Lindner, M. & Eickelberg, O. Multiplex profiling of cellular invasion in 3D cell culture models. PLoS One 8, e63121 (2013).
20. Lederle, W. et al. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 31, 1175-1184 (2010).
21. Sabeh, F., Li, X. Y., Saunders, T. L., Rowe, R. G. & Weiss, S. J. Secreted versus membrane-Anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J Biol Chem 284, 23001-23011 (2009).
22. Imai, K. et al. Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-beta1. World J Surg Oncol 11, 113 (2013).
23. Lino Cardenas, C. L. et al. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbetainduced lung fibroblast activation by targeting caveolin-1. PLoS Genet 9, e1003291 (2013).
24. Matsuda, Y., Schlange, T., Oakeley, E. J., Boulay, A. & Hynes, N. E. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11, R32 (2009).
25. White, E. S. et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 168, 436-442 (2003).
26. Kotelevets, L. et al. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. Faseb j 19, 115-117 (2005).
27. Kramer, A., Green, J., Pollard, J., Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523-530 (2014).
28. Hinz, B. et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180, 1340-1355 (2012).
29. Crestani, B., Besnard, V., Plantier, L., Borensztajn, K. & Mailleux, A. Fibroblasts: the missing link between fibrotic lung diseases of different etiologies? Respir Res 14, 81 (2013).
30. Lecomte, J. et al. Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor. Neoplasia 14, 943-951 (2012).
31. Rosas, I. O. et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5, e93 (2008).
32. Nkyimbeng, T. et al. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis. PLoS One 8, e73279 (2013).
33. Wang, X. M. et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203, 2895-2906 (2006).
34. Goetz, J. G. et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146, 148-163 (2011).
35. Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617 (1998).
36. White, E. S. et al. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 173, 112-121 (2006).
37. Liliental, J. et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 10, 401-404 (2000).
38. Tamura, M., Gu, J., Takino, T. & Yamada, K. M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59, 442-449 (1999).
39. Mouw, J. K. et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. 20, 360-367 (2014).
40. Xia, H. et al. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176, 2626-2637 (2010).
41. Esteve, P. & Bovolenta, P. The advantages and disadvantages of sfrp1 and sfrp2 expression in pathological events. Tohoku J Exp Med 221, 11-17 (2010).
42. Fukui, T. et al. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in nonsmall-cell lung cancer. Oncogene 24, 6323-6327 (2005).
43. Russell, S. B. et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 130, 2489-2496 (2010).
44. Dees, C. et al. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann Rheum Dis 73, 1232-1239 (2014).
45. Hsu, E. et al. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63, 783-794 (2011).
46. Ren, J. et al. sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line. Cancer Biother Radiopharm 28, 565-571 (2013).
47. Fernandez, I. E. & Eickelberg, O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 9, 111-116 (2012).
48. Ampe, C., Libbrecht, J. & Van Troys, M. beta-Actin knock-out mouse embryonic fibroblasts show increased expression of LIM-, CH-, EFh-domain containing proteins with predicted common upstream regulators. Cytoskeleton (Hoboken) 70, 766-774 (2013).
49. Meier-Abt, F. et al. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res 15, R36 (2013).
50. Sachs, Z. et al. NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia. Blood 124, 3274-3283 (2014).
51. Lu, Z., Jiang, G., Blume-Jensen, P. & Hunter, T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21, 4016-4031 (2001).
52. Gobin, A. S. & West, J. L. Effects of epidermal growth factor on fibroblast migration through biomimetic hydrogels. Biotechnol Prog 19, 1781-1785 (2003).
53. Shimizu, T. et al. Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma. Mol Cancer Res 10, 454-468 (2012).
54. Strutz, F. et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 59, 579-592 (2001).
55. Inoue, Y., King, T. E., Jr., Tinkle, S. S., Dockstader, K. & Newman, L. S. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol 149, 2037-2054 (1996).
56. Lin, N. et al. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats. Am J Physiol Cell Physiol 301, C469-477 (2011).
57. Aono, Y. et al. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. Am J Respir Cell Mol Biol 51, 793-801 (2014).
58. Tudoran, O. M. et al. PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation. J Cell Mol Med (2014).
59. Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M. & Westermark, B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A 90, 393-397 (1993).
60. Rainer, J., Sanchez-Cabo, F., Stocker, G., Sturn, A. & Trajanoski, Z. CARMAweb: comprehensive R-And bioconductor-based web service for microarray data analysis. Nucleic Acids Res 34, W498-503 (2006).